Essel: Looking for consolidation benefits - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Essel: Looking for consolidation benefits

May 16, 2001

Essel Propack Limited (formerly Essel Packaging) has reported a net profit growth of 16% to Rs 95 m in 4QFY01. The company's turnover during the period saw a 23% growth YoY. Essel finished FY01 with a 10% turnover growth and an 18% jump in net profit.

(Rs m) 4QFY00 4QFY01 Change FY00 FY01 Change
Net Sales 469 578 23.2% 2,070 2,281 10.2%
Other Income 18 57 215.0% 40 85 112.5%
Expenditure 287 416 44.9% 1,299 1,486 14.4%
Operating Profit (EBDIT) 182 162 -11.2% 771 794 3.0%
Operating Profit Margin (%) 38.8% 28.0%   37.2% 34.8%  
Interest 9 3 -64.4% 25 6 -74.8%
Depreciation 74 69 -6.2% 278 279 0.2%
Profit before Tax 118 146 23.5% 507 594 17.2%
Exceptional expenses - -     -  
Tax 36 51 41.7% 141 161 14.2%
Profit after Tax/(Loss) 82 95 15.5% 366 433 18.4%
Net profit margin (%) 17.5% 16.4%   17.7% 19.0%  
No. of Shares (eoy) (m) 14.5 24.3   14.5 24.3  
Diluted no. of shares (m) 24.3 24.3   24.3 24.3  
Earnings per share* 13.5 15.6   15.0 17.8  
Current P/e ratio         9.7  

Essel makes lamitubes used in packaging consumer products like toothpaste, cosmetics and pharmaceuticals. It is the world's largest producer of collapsible lamitubes with a current capacity of more than 2 bn tubes post its merger with Propack in FY01. Essel's early entry into the lamitube market and the scale of its operations gives it tremendous cost advantages over any new entrant. It is also backwardly integrated into web-making for lamitubes.

The company has not merged the accounts of Propack with itself in FY01. Therefore, the real benefits of the consolidation will come into effect from FY02. At the analyst meet last year the management had stated that the combined turnover of Essel Propack will touch Rs 15 bn by FY05, thatís a CAGR growth of 60% in the next four years. Similarly, the net profit of the combined entity is estimated (by the Essel management) to touch Rs 3.3 bn by FY05. One cannot really comment on these targets unless one sees Essel Propack's merged numbers.

The company had allotted bonus shares in the ratio of 3:5 in January 2001.Consequently the paid up capital has increased to Rs 243 m. Essel's board of directors has recommended maintaining the dividend at 54% on the post bonus increased share capital.

At the current price of Rs 173 the stock trades at a P/E multiple of 9.7 times its FY01 earnings.

Equitymaster requests your view! Post a comment on "Essel: Looking for consolidation benefits ". Click here!


More Views on News

ESSEL PROPACK Announces Quarterly Results (1QFY21); Net Profit Up 13.3% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, ESSEL PROPACK has posted a net profit of Rs 457 m (up 13.3% YoY). Sales on the other hand came in at Rs 7 bn (up 17.7% YoY). Read on for a complete analysis of ESSEL PROPACK's quarterly results.

ESSEL PROPACK Announces Quarterly Results (4QFY20); Net Profit Down 7.8% (Quarterly Result Update)

May 27, 2020 | Updated on May 27, 2020

For the quarter ended March 2020, ESSEL PROPACK has posted a net profit of Rs 491 m (down 7.8% YoY). Sales on the other hand came in at Rs 7 bn (down 0.7% YoY). Read on for a complete analysis of ESSEL PROPACK's quarterly results.

ESSEL PROPACK 2018-19 Annual Report Analysis (Annual Result Update)

Jun 5, 2019 | Updated on Jun 5, 2019

Here's an analysis of the annual report of ESSEL PROPACK for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ESSEL PROPACK. Also includes updates on the valuation of ESSEL PROPACK.

More Views on News

Most Popular

Why Gold Hit Lower Circuit (Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks (Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021 (Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond (Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


Jan 22, 2021 (Close)